Biopharma

Somerset-Based Whizai Gets $4 Million to Make Business Intelligence Easy for Pharma and Life Sciences

Esther Surden | NJ Tech Weekly

WhizAI (Somerset) has an artificial intelligence (AI) technology for the business end of the pharmaceutical and life-science industries that some observers have described as “magical.” The company recently secured an additional $4 million in funding to further scale its software offering. According to WhizAI cofounder and CEO Rohit Vashisht, he and cofounder Amitabh Patil started the company in 2017 with the …

EY names Entrepreneur of the Year New Jersey Award finalists

Eric Strauss | ROI-NJ

Ernst & Young LLP has announced the 30 finalists for its Entrepreneur of the Year 2020 New Jersey Award, with honorees from sectors ranging from food to pharma and finance. The Entrepreneur of the Year program honors business leaders who are building and sustaining groundbreaking companies that transform the world, the professional services firm — which has a major presence …

Innovating During COVID-19: New Jersey’s Next Era in Life Sciences

Choose New Jersey | Area Development

Following 150 years of global leadership in life sciences, cell and gene therapy (CGT) is rapidly accelerating within the New Jersey ecosystem. As winter began to wane this year, the world was upended by the COVID-19 pandemic. Unprecedented levels of interest in cell and gene therapies have followed, with research and development (R&D) facilities testing different potential solutions, such as …

RUCDR Infinite Biologics to Provide 30,000 Rapid Response COVID-19 Tests Per Day

Jim Pytell | New Jersey Business Magazine

At what was his 100th COVID-19 press briefing, Gov. Phil Murphy today announced that RUCDR Infinite Biologics, a unit of Rutgers’ Human Genetics Institute of New Jersey, will provide 30,000 rapid-response saliva-based coronavirus tests per day. “Having these tests means we now have 30,000 tests a day that come with a 48-hour turnaround. As test turnaround has lagged nationally given …

BioAegis Therapeutics to Proceed with Phase 2 Trial of Gelsolin COVID-19 Treatment

NEW JERSEY BUSINESS MAGAZINE

North Brunswick-based BioAegis Therapeutics Inc., has received regulatory clearance from the Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin (rhu-pGSN) in hospitalized patients with severe COVID-19 pneumonia. BioAegis expects to recruit its first patient and begin the study shortly at Hospital Universitari Sant Joan …

Hackensack Meridian CDI, Merck to Collaborate on COVID-19 Research

New Jersey Business Magazine

The collaborative work aims to find drugs to treat the pandemic The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck to investigate drugs for treating COVID-19. The CDI will work with Merck to identify candidate treatments for the still-spreading pandemic. “The CDI was started less than a year ago to provide dynamic research …

BD Launches Portable Antigen Test to Detect SARS-CoV-2 in 15 Minutes

NEW JERSEY BUSINESS MAGAZINE

BD (Becton, Dickinson and Company), a Franklin Lakes-based global medical technology company, announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor™ Plus System. The launch of this new assay that delivers results in 15 minutes on an easy-to-use, highly portable …

PTC Therapeutics taps experimental cancer drug for new COVID-19 trial

Ben Adams | Fierce Biotech

PTC Therapeutics is throwing its hat in the ring for a potential reworked pipeline med against COVID-19. The biopharma, which has been focused on rare diseases, is tapping its early-stage cancer drug, currently in a test for certain leukemias, to see whether it can help patients afflicted with the disease. It is any day now kick-starting a phase 2/3 trial …

New Jersey Solutions For Cell And Gene Development and Manufacturing

Louis Garguilo | Outsourced Pharma

New Jersey’s first university-based, cell-and-gene-therapy development and manufacturing innovation center for-hire, was founded on the answers to these questions of the biopharma industry: What are your main challenges in manufacturing gene and cell therapy products? What are your challenges in recruiting talent? What do you need to effectively train your current employees? Answers poured in pre-establishment of the center from …

WHAT CAN CHOOSE New Jersey DO FOR YOU

Relocation & Expansion Services

We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.

Site Visits

We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.

Economic Development Connections

Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.

Carly Wronko
Marketing Manager
Tiffany Hess-Bennette
Creative Content Specialist